-The United Nations One in three people is now covered by at least one life-saving measure to limit tobacco use, according to a United Nations report which highlights the progress over the past five years of reducing potential smokers through advertising bans and awareness campaigns. According to the report on the Global Tobacco Epidemic 2013, the number of people covered by bans on tobacco advertising, promotion and sponsorship increased by almost 400...

-The Telegraph The proliferation and sales of anti-Diabetes combination pills that contain two drugs to control blood sugar has stirred concerns in medical circles that a large proportion of Diabetes patients in India are not receiving ideal treatment. A study by Indian and British researchers has shown that such two-drug combo pills accounted for more than half of the sales of all oral anti-Diabetes medications in India last year, although doctors say...

-The Times of India LUCKNOW: In a state infamous for malnutrition, one out of five teens going to private schools is either overweight or obese. This has been revealed in a study conducted by National Diabetes, Obesity and Cholesterol Foundation (N-DOC). The study covered more than 49,000 school children in eight cities, including 23,006 children in Lucknow, Agra and Allahabad. The other cities were New Delhi, Jaipur, Mumbai, Dehradun and Pantnagar. The...

-The Hindustan Times The recent release of The Lancet's special edition on Maternal and Child Nutrition in Delhi provided an occasion to debate the relevance of its recommendations for India. The discourse was enlivened by a statement, released ahead of the event by several Indian health experts, challenging the content and intent of some of the suggested interventions. Three authors of The Lancet series and many of the critics who issued that statement...

-The Times of India MUMBAI: The government has banned three popular medicines-the widely prescribed anti-Diabetes drug pioglitazone, painkiller analgin and anti-depressant deanxit-in the wake of health risks associated with them. While it's believed that pioglitazone can cause heart failure and increases the risk of bladder cancer, analgin has been discarded the world over on grounds of patient safety. Deanxit, on the other hand is a harmful combination, which has been long...